Claire E. Parker

5.1k total citations · 1 hit paper
80 papers, 2.7k citations indexed

About

Claire E. Parker is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Claire E. Parker has authored 80 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Genetics, 52 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Claire E. Parker's work include Inflammatory Bowel Disease (59 papers), Microscopic Colitis (49 papers) and Autoimmune and Inflammatory Disorders (12 papers). Claire E. Parker is often cited by papers focused on Inflammatory Bowel Disease (59 papers), Microscopic Colitis (49 papers) and Autoimmune and Inflammatory Disorders (12 papers). Claire E. Parker collaborates with scholars based in Canada, United States and Netherlands. Claire E. Parker's co-authors include Brian G. Feagan, Vipul Jairath, John K MacDonald, Tran M Nguyen, Simon Nightingale, Charles R. M. Bangham, Christopher Ma, Reena Khanna, Susan Daenke and Vipul Jairath and has published in prestigious journals such as Gastroenterology, Journal of Virology and Gut.

In The Last Decade

Claire E. Parker

79 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review

2019 212 citations Dominik Bettenworth, Arne Bokemeyer et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claire E. Parker Canada	32	1.5k	1.2k	837	726	356	80	2.7k
Paul Gibbs United Kingdom	28	90 0.1×	669 0.5×	1.3k 1.6×	324 0.4×	124 0.3×	94	2.7k
G. B. Clements United Kingdom	25	448 0.3×	738 0.6×	192 0.2×	448 0.6×	45 0.1×	58	2.0k
Salvatore Sampognaro Italy	21	332 0.2×	433 0.3×	179 0.2×	2.0k 2.7×	89 0.3×	26	3.1k
William H. Kutteh United States	40	297 0.2×	388 0.3×	398 0.5×	2.3k 3.2×	146 0.4×	140	5.5k
A. B. Ajdukiewicz United Kingdom	20	78 0.1×	408 0.3×	172 0.2×	324 0.4×	213 0.6×	45	1.1k
Aaron Webster United Kingdom	24	210 0.1×	981 0.8×	187 0.2×	826 1.1×	38 0.1×	59	2.2k
Margo C. Honeyman Australia	30	2.0k 1.3×	440 0.4×	1.3k 1.6×	1.2k 1.6×	11 0.0×	62	3.3k
Giuseppe Longo Italy	26	157 0.1×	533 0.4×	285 0.3×	213 0.3×	20 0.1×	87	2.3k
Jorge Carrillo Spain	29	379 0.2×	377 0.3×	466 0.6×	577 0.8×	23 0.1×	113	2.7k
Harald Peeters Belgium	20	839 0.5×	530 0.4×	287 0.3×	468 0.6×	7 0.0×	58	1.7k

Countries citing papers authored by Claire E. Parker

Since Specialization

Citations

This map shows the geographic impact of Claire E. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire E. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire E. Parker more than expected).

Fields of papers citing papers by Claire E. Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire E. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire E. Parker. The network helps show where Claire E. Parker may publish in the future.

Co-authorship network of co-authors of Claire E. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Claire E. Parker. A scholar is included among the top collaborators of Claire E. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire E. Parker. Claire E. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goodsall, Thomas M, Claire E. Parker, Alice S. Day, et al.. (2025). Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply. Alimentary Pharmacology & Therapeutics. 62(8). 855–856.

Goodsall, Thomas M, Claire E. Parker, Alice S. Day, et al.. (2025). Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal Loading. Alimentary Pharmacology & Therapeutics. 62(8). 799–808. 2 indexed citations

Mathers, John C., Carmen Martín-Ruiz, Claire E. Parker, et al.. (2024). The association between selenium status and cognitive decline in very old adults: The Newcastle 85+ Study. Proceedings of The Nutrition Society. 83(OCE2). 1 indexed citations

Parker, Claire E., John K MacDonald, Joshua Chang, et al.. (2023). Use of external control arms in immune-mediated inflammatory diseases: a systematic review. BMJ Open. 13(12). e076677–e076677. 5 indexed citations

Solitano, Virginia, Sudheer K. Vuyyuru, John K MacDonald, et al.. (2023). Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. Journal of Crohn s and Colitis. 17(11). 1800–1816. 31 indexed citations

Solitano, Virginia, David F. Schaeffer, Malcolm Hogan, et al.. (2023). Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn’s Disease Activity. Clinical Gastroenterology and Hepatology. 22(9). 1898–1907.e25. 4 indexed citations

Hanžel, Jurij, Alexandra C. Istl, Claire E. Parker, et al.. (2021). Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn’s Disease After Elective Surgery: Meta-Analysis. Digestive Diseases and Sciences. 67(2). 646–660. 5 indexed citations

Sedaño, Rocío, Malcolm Hogan, Guangyong Zou, et al.. (2021). Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn’s Disease: Meta-Analysis of Randomised Controlled Trials. Journal of Crohn s and Colitis. 16(5). 717–736. 17 indexed citations

Sedaño, Rocío, Tran M Nguyen, Florian Rieder, et al.. (2021). Disease Activity Indices for Pouchitis: A Systematic Review. Inflammatory Bowel Diseases. 28(4). 622–638. 14 indexed citations

10.

Battat, Robert, Niels Vande Casteele, Rish K. Pai, et al.. (2020). Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study. Alimentary Pharmacology & Therapeutics. 52(10). 1574–1582. 7 indexed citations

11.

Bettenworth, Dominik, Arne Bokemeyer, Mark E. Baker, et al.. (2019). Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut. 68(6). 1115–1126. 212 indexed citations breakdown →

12.

Battat, Robert, Marjolijn Duijvestein, Leonardo Guizzetti, et al.. (2019). Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The American Journal of Gastroenterology. 114(5). 733–745. 41 indexed citations

13.

Dellon, Evan S., Claire E. Parker, Brian G. Feagan, et al.. (2019). Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review. Drugs. 79(13). 1419–1434. 24 indexed citations

14.

Ma, Christopher, Leonardo Guizzetti, Remo Panaccione, et al.. (2018). Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis. Alimentary Pharmacology & Therapeutics. 47(12). 1578–1596. 24 indexed citations

15.

Pai, Rish K., Vipul Jairath, Niels Vande Casteele, et al.. (2018). The emerging role of histologic disease activity assessment in ulcerative colitis. Gastrointestinal Endoscopy. 88(6). 887–898. 100 indexed citations

16.

Lee, Matthew J., Claire E. Parker, Sarah R. Taylor, et al.. (2018). Efficacy of Medical Therapies for Fistulizing Crohn’s Disease: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 16(12). 1879–1892. 94 indexed citations

17.

D’Haens, Geert, William J. Sandborn, Guangyong Zou, et al.. (2017). Randomised non‐inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild‐to‐moderate ulcerative colitis. Alimentary Pharmacology & Therapeutics. 46(3). 292–302. 38 indexed citations

18.

Ma, Christopher, Remo Panaccione, Richard N. Fedorak, et al.. (2017). Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set. Clinical Gastroenterology and Hepatology. 16(5). 637–647.e13. 45 indexed citations

19.

Khanna, Reena, Nilesh Chande, Séverine Vermeire, et al.. (2016). The Next Wave of Biological Agents for the Treatment of IBD. Inflammatory Bowel Diseases. 22(7). 1737–1743. 6 indexed citations

20.

Parker, Claire E., Ganesh Cherala, Yoshinobu Koguchi, et al.. (2016). Inflammation Causes Resistance to Anti-CD20–Mediated B Cell Depletion. American Journal of Transplantation. 16(11). 3139–3149. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact